WACKER CHEMIE AG (WCH.DE) Fundamental Analysis & Valuation

FRA:WCH • DE000WCH8881

Current stock price

89.05 EUR
-1.35 (-1.49%)
Last:

This WCH.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. WCH.DE Profitability Analysis

1.1 Basic Checks

  • WCH had negative earnings in the past year.
  • In the past year WCH had a positive cash flow from operations.
  • WCH had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years WCH had a positive operating cash flow.
WCH.DE Yearly Net Income VS EBIT VS OCF VS FCFWCH.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B

1.2 Ratios

  • WCH's Return On Assets of -10.93% is on the low side compared to the rest of the industry. WCH is outperformed by 79.71% of its industry peers.
  • The Return On Equity of WCH (-25.42%) is worse than 85.51% of its industry peers.
Industry RankSector Rank
ROA -10.93%
ROE -25.42%
ROIC N/A
ROA(3y)-1.24%
ROA(5y)3.9%
ROE(3y)-3.52%
ROE(5y)8.38%
ROIC(3y)N/A
ROIC(5y)N/A
WCH.DE Yearly ROA, ROE, ROICWCH.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

1.3 Margins

  • WCH's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 12.08%, WCH is not doing good in the industry: 81.16% of the companies in the same industry are doing better.
  • WCH's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for WCH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.08%
OM growth 3Y-66.98%
OM growth 5Y-40.19%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.7%
GM growth 5Y-5.97%
WCH.DE Yearly Profit, Operating, Gross MarginsWCH.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

4

2. WCH.DE Health Analysis

2.1 Basic Checks

  • WCH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, WCH has about the same amount of shares outstanding.
  • The number of shares outstanding for WCH remains at a similar level compared to 5 years ago.
  • WCH has a worse debt/assets ratio than last year.
WCH.DE Yearly Shares OutstandingWCH.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
WCH.DE Yearly Total Debt VS Total AssetsWCH.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • WCH has an Altman-Z score of 2.41. This is not the best score and indicates that WCH is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.41, WCH is in line with its industry, outperforming 52.17% of the companies in the same industry.
  • WCH has a Debt/Equity ratio of 0.61. This is a neutral value indicating WCH is somewhat dependend on debt financing.
  • WCH has a Debt to Equity ratio of 0.61. This is in the lower half of the industry: WCH underperforms 60.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Altman-Z 2.41
ROIC/WACCN/A
WACC5.89%
WCH.DE Yearly LT Debt VS Equity VS FCFWCH.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • WCH has a Current Ratio of 3.06. This indicates that WCH is financially healthy and has no problem in meeting its short term obligations.
  • WCH has a better Current ratio (3.06) than 84.06% of its industry peers.
  • WCH has a Quick Ratio of 1.93. This is a normal value and indicates that WCH is financially healthy and should not expect problems in meeting its short term obligations.
  • With an excellent Quick ratio value of 1.93, WCH belongs to the best of the industry, outperforming 82.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.06
Quick Ratio 1.93
WCH.DE Yearly Current Assets VS Current LiabilitesWCH.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

3

3. WCH.DE Growth Analysis

3.1 Past

  • The earnings per share for WCH have decreased strongly by -483.88% in the last year.
  • The Revenue has decreased by -3.90% in the past year.
  • Measured over the past years, WCH shows a small growth in Revenue. The Revenue has been growing by 3.17% on average per year.
EPS 1Y (TTM)-483.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-676.51%
Revenue 1Y (TTM)-3.9%
Revenue growth 3Y-12.58%
Revenue growth 5Y3.17%
Sales Q2Q%-6.07%

3.2 Future

  • WCH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.76% yearly.
  • WCH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.29% yearly.
EPS Next Y101.46%
EPS Next 2Y45.35%
EPS Next 3Y29.8%
EPS Next 5Y18.76%
Revenue Next Year0.63%
Revenue Next 2Y2.85%
Revenue Next 3Y2.79%
Revenue Next 5Y3.29%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
WCH.DE Yearly Revenue VS EstimatesWCH.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
WCH.DE Yearly EPS VS EstimatesWCH.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 10 -10 20

1

4. WCH.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for WCH. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 327.76 indicates a quite expensive valuation of WCH.
  • Based on the Price/Forward Earnings ratio, WCH is valued a bit more expensive than the industry average as 73.91% of the companies are valued more cheaply.
  • WCH's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 38.18.
Industry RankSector Rank
PE N/A
Fwd PE 327.76
WCH.DE Price Earnings VS Forward Price EarningsWCH.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of WCH is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.71
WCH.DE Per share dataWCH.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as WCH's earnings are expected to grow with 29.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.35%
EPS Next 3Y29.8%

0

5. WCH.DE Dividend Analysis

5.1 Amount

  • WCH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

WCH.DE Fundamentals: All Metrics, Ratios and Statistics

WACKER CHEMIE AG

FRA:WCH (4/14/2026, 7:00:00 PM)

89.05

-1.35 (-1.49%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-11
Earnings (Next)04-29
Inst Owners10.74%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.64B
Revenue(TTM)8.30B
Net Income(TTM)-915.10M
Analysts66.09
Price Target75.36 (-15.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend2.5
Dividend Growth(5Y)38.02%
DP-13.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-649.33%
Min EPS beat(2)-1153.62%
Max EPS beat(2)-145.05%
EPS beat(4)0
Avg EPS beat(4)-424.02%
Min EPS beat(4)-1153.62%
Max EPS beat(4)-145.05%
EPS beat(8)2
Avg EPS beat(8)-208.74%
EPS beat(12)4
Avg EPS beat(12)-140.92%
EPS beat(16)6
Avg EPS beat(16)-104.81%
Revenue beat(2)1
Avg Revenue beat(2)-0.08%
Min Revenue beat(2)-3.44%
Max Revenue beat(2)3.28%
Revenue beat(4)2
Avg Revenue beat(4)-0.13%
Min Revenue beat(4)-3.44%
Max Revenue beat(4)3.28%
Revenue beat(8)2
Avg Revenue beat(8)-0.95%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.58%
PT rev (3m)7.68%
EPS NQ rev (1m)45.83%
EPS NQ rev (3m)-300%
EPS NY rev (1m)-58.57%
EPS NY rev (3m)-71.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.38%
Revenue NY rev (3m)-0.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 327.76
P/S 0.56
P/FCF N/A
P/OCF 8.56
P/B 1.29
P/tB 1.38
EV/EBITDA 12.71
EPS(TTM)-18.58
EYN/A
EPS(NY)0.27
Fwd EY0.31%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)10.4
OCFY11.68%
SpS159.23
BVpS69.02
TBVpS64.46
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.93%
ROE -25.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.08%
FCFM N/A
ROA(3y)-1.24%
ROA(5y)3.9%
ROE(3y)-3.52%
ROE(5y)8.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.09%
ROCE(5y)9.46%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-66.98%
OM growth 5Y-40.19%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.7%
GM growth 5Y-5.97%
F-Score4
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Debt/EBITDA 5.54
Cap/Depr 91.23%
Cap/Sales 6.66%
Interest Coverage N/A
Cash Conversion 136.16%
Profit Quality N/A
Current Ratio 3.06
Quick Ratio 1.93
Altman-Z 2.41
F-Score4
WACC5.89%
ROIC/WACCN/A
Cap/Depr(3y)127.28%
Cap/Depr(5y)120.18%
Cap/Sales(3y)10.49%
Cap/Sales(5y)8.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-483.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-676.51%
EPS Next Y101.46%
EPS Next 2Y45.35%
EPS Next 3Y29.8%
EPS Next 5Y18.76%
Revenue 1Y (TTM)-3.9%
Revenue growth 3Y-12.58%
Revenue growth 5Y3.17%
Sales Q2Q%-6.07%
Revenue Next Year0.63%
Revenue Next 2Y2.85%
Revenue Next 3Y2.79%
Revenue Next 5Y3.29%
EBIT growth 1Y-158.94%
EBIT growth 3Y-71.13%
EBIT growth 5Y-38.3%
EBIT Next Year918.05%
EBIT Next 3Y136.31%
EBIT Next 5Y75.76%
FCF growth 1Y96.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y74.81%
OCF growth 3Y-21.59%
OCF growth 5Y-9.09%

WACKER CHEMIE AG / WCH.DE Fundamental Analysis FAQ

What is the fundamental rating for WCH stock?

ChartMill assigns a fundamental rating of 3 / 10 to WCH.DE.


What is the valuation status for WCH stock?

ChartMill assigns a valuation rating of 1 / 10 to WACKER CHEMIE AG (WCH.DE). This can be considered as Overvalued.


What is the profitability of WCH stock?

WACKER CHEMIE AG (WCH.DE) has a profitability rating of 2 / 10.


How financially healthy is WACKER CHEMIE AG?

The financial health rating of WACKER CHEMIE AG (WCH.DE) is 4 / 10.